Clinical Trial

Leveraging Project ECHO for Improved Cervical Cancer Screening in Ethiopia

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Project TICHILALECH ("she can" in Amharic), a five-year, implementation science study, is focused on improving cervical cancer screening, triage, and treatment and integration with human immunodeficiency virus (HIV) care at five Ethiopian hospitals, with a focus on human papillomavirus (HPV) self-collection as the recommended screening strategy for people living with HIV (PLHIV). To improve implementation of screening and treatment, Project ECHO (Extension for Community Healthcare Outcomes), a peer-based, virtual, knowledge sharing model, will be used to convene healthcare providers and stakeholders over a period of approximately three years (2026-2029). A customized curriculum is developed featuring didactic lectures, case-based presentations, and experience sharing for peer-mentoring. A pre/post study design will measure changes in delivery of clinical services, such as the proportion of HPV-positive patients that are appropriately triaged and treated, before and after each hospital's participation in the TICHILALECH ECHO intervention.
Trial Details
NCT Number NCT07678047
Lead Sponsor Albert Einstein College of Medicine
Collaborators: National Cancer Institute (NCI), Addis Ababa University, University of New Mexico, University of Arizona
Conditions Cervical Carcinoma, Human Papilloma Virus (HPV)
Enrollment 60 participants
Start Date 2026-06-24
Primary Completion 2029-07 (estimated)
Study Completion 2029-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-01